Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi Arabia

Background Hepatic damage is one of the common forms of extra pulmonary organ destructions among patients with COVID-19 infections.Aim To evaluate the prognosis of liver damage among COVID-19 patients based on their liver enzymes profile.Methods A retrospective study was done to evaluate the records...

Full description

Bibliographic Details
Main Author: Omar AlOmair
Format: Article
Language:English
Published: BMJ Publishing Group 2023-08-01
Series:BMJ Open Gastroenterology
Online Access:https://bmjopengastro.bmj.com/content/10/1/e001121.full
_version_ 1827153538005860352
author Omar AlOmair
author_facet Omar AlOmair
author_sort Omar AlOmair
collection DOAJ
description Background Hepatic damage is one of the common forms of extra pulmonary organ destructions among patients with COVID-19 infections.Aim To evaluate the prognosis of liver damage among COVID-19 patients based on their liver enzymes profile.Methods A retrospective study was done to evaluate the records of the hospitably admitted patient due to COVID-19 infection.Retrieved data included clinical presentation and investigation either imaging or laboratory with special investing in liver function tests.Result We reviewed 442 patients who were diagnosed with COVID-19 infection.They were 64.5% of female patients and 35.5% of male patients. Their mean age was 54.5%, most of them were Saudi (76.7%) and the overall mortality reached up to (20.4%).Conclusion This large cohort of 442 patients has shown that liver damage may be an independent prognostic factor for morbidities and mortality among COVID-19 patients. It also showed the importance of liver function enzymes screening as a predictor for the outcome of those patients.
first_indexed 2024-03-08T18:21:55Z
format Article
id doaj.art-bc4ca74b5b6b4764b84e7417d67ad198
institution Directory Open Access Journal
issn 2054-4774
language English
last_indexed 2025-03-20T22:23:21Z
publishDate 2023-08-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Gastroenterology
spelling doaj.art-bc4ca74b5b6b4764b84e7417d67ad1982024-08-08T13:45:10ZengBMJ Publishing GroupBMJ Open Gastroenterology2054-47742023-08-0110110.1136/bmjgast-2023-001121Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi ArabiaOmar AlOmair0Internal Medicine Department Gastroenterology division, King Faisal University, Al-Hasa, Saudi ArabiaBackground Hepatic damage is one of the common forms of extra pulmonary organ destructions among patients with COVID-19 infections.Aim To evaluate the prognosis of liver damage among COVID-19 patients based on their liver enzymes profile.Methods A retrospective study was done to evaluate the records of the hospitably admitted patient due to COVID-19 infection.Retrieved data included clinical presentation and investigation either imaging or laboratory with special investing in liver function tests.Result We reviewed 442 patients who were diagnosed with COVID-19 infection.They were 64.5% of female patients and 35.5% of male patients. Their mean age was 54.5%, most of them were Saudi (76.7%) and the overall mortality reached up to (20.4%).Conclusion This large cohort of 442 patients has shown that liver damage may be an independent prognostic factor for morbidities and mortality among COVID-19 patients. It also showed the importance of liver function enzymes screening as a predictor for the outcome of those patients.https://bmjopengastro.bmj.com/content/10/1/e001121.full
spellingShingle Omar AlOmair
Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi Arabia
BMJ Open Gastroenterology
title Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi Arabia
title_full Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi Arabia
title_fullStr Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi Arabia
title_full_unstemmed Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi Arabia
title_short Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi Arabia
title_sort liver enzymes among covid 19 patients in al ahsa region of saudi arabia
url https://bmjopengastro.bmj.com/content/10/1/e001121.full
work_keys_str_mv AT omaralomair liverenzymesamongcovid19patientsinalahsaregionofsaudiarabia